T. Shonk et Bd. Ross, ROLE OF INCREASED CEREBRAL MYOINOSITOL IN THE DEMENTIA OF DOWN-SYNDROME, Magnetic resonance in medicine, 33(6), 1995, pp. 858-861
The purpose of this study was to determine cerebral myoinositol (mI) i
n adults with Down syndrome (DS), and to trace the chronobiology of DS
to Alzheimer disease (AD). AD has characteristic neuropathology of ne
urofibrillary plaques and tangles; indirect evidence links this to ear
lier deposition of beta-amyloid. Elevated mI, which distinguishes AD f
rom other common dementias, is also elevated in 23 young patients who
have DS without dementia. In one patient who has DS with dementia, mi
is elevated and N-acetylaspartate (NAA) decreased. The similarity to A
D is striking and may suggest a progressive neurochemical disorder in
which elevation of mi precede loss of NAA in both AD and DS.